Used in research and development for targeting IL-8 (CXCL8), a key chemokine involved in inflammation and immune responses. This reference antibody serves as a critical tool in studying inflammatory diseases such as rheumatoid arthritis, psoriasis, and chronic obstructive pulmonary disease (COPD). It is also applied in oncology research due to IL-8's role in tumor progression, angiogenesis, and metastasis. The antibody helps neutralize IL-8 activity in vitro and in vivo, enabling validation of IL-8 as a therapeutic target. Additionally, it supports assay development, biomarker analysis, and pharmacodynamic studies in preclinical models. Its use is primarily restricted to laboratory and drug discovery settings, especially in projects related to inflammation, cancer, and autoimmune disorders.